Multikinase inhibitors: a new option for the treatment of thyroid cancer. [electronic resource]
- Nature reviews. Endocrinology Aug 2011
- 617-24 p. digital
Publication Type: Journal Article; Review
1759-5037
10.1038/nrendo.2011.141 doi
Clinical Trials as Topic Clinical Trials, Phase III as Topic Humans Mitogen-Activated Protein Kinases--antagonists & inhibitors Phosphatidylinositol 3-Kinases--metabolism Phosphoinositide-3 Kinase Inhibitors Protein Kinase Inhibitors--pharmacology Thyroid Neoplasms--drug therapy